Renpei Kato

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Cancer medicine

International journal of clinical oncology

International journal of urology : official journal of the Japanese Urological Association

Expert review of anticancer therapy

Iwate Medical University

Iwate Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Iwate Medical University

Japan

Project Lecturer :: Urology

Iwate Medical University Morioka JP

Japan

Assistant Professor :: Urology

Tokushima Daigaku

Japan

Research fellow :: Division of Genome Medicine, Institute for Genome Research

Iwate Medical University

Japan

Medical staff

Education History

Iwate Medical University

Japan

PHD

Publications

Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya, Wataru Obara
Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study. International journal of clinical oncology (2023)
Tomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, Kazuyuki Numakura, Yumina Muto, Renpei Kato, Takahiro Kojima, Yoshihide Kawasaki, Kento Morozumi, Syuya Kandori, Sadafumi Kawamura, Hiroyuki Nishiyama, Akihiro Ito, Tomonori Habuchi, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Yoshiyuki Kojima
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database. Cancer medicine (2023)
Yoichiro Kato, Hidenori Akaihata, Kentaro Takezawa, Shigekatsu Maekawa, Kanako Matsuoka, Shinichiro Fukuhara, Renpei Kato, Yoshiyuki Kojima, Norio Nonomura, Wataru Obara
Association between nocturnal polyuria and 24-h blood pressure fluctuations in males with lower urinary tract symptoms: A multicenter prospective study. International journal of urology : official journal of the Japanese Urological Association (2023)
Wataru Obara, Renpei Kato
Editorial Comment to Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up. International journal of urology : official journal of the Japanese Urological Association (2022)
Ryuta Sobu, Kazuyuki Numakura, Sei Naito, Shingo Hatakeyama, Renpei Kato, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Syuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Tomonori Habuchi
Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study. Cancer medicine (2022)
Renpei Kato, Wataru Obara
Anti-PD-1/PD-L1 therapy for renal cell carcinoma: challenges in the development of predictive biomarkers. Expert review of anticancer therapy 22 (7) (2022)
Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya, Wataru Obara
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. International journal of clinical oncology 27 (3) (2022)
Yoichiro Kato, Daiki Ikarashi, Daichi Kikuchi, Misato Takayama, Seiko Kanzaki, Akito Ito, Daichi Tamura, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Wataru Obara
Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study. The Journal of international medical research 49 (8) (2021)
Kazuyuki Numakura, Yumin Muto, Sei Naito, Shingo Hatakeyama, Renpei Kato, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Syuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Tomonori Habuchi
Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era. Cancer medicine 10 (17) (2021)
Renpei Kato, Yoichiro Kato, Tomohiko Matsuura, Mitsugu Kanehira, Ryo Takata, Wataru Obara
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC cancer 17 (1) (2017)

Renpei Kato.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Renpei Kato